window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMOs & Manufacturing

  • CDMOs & Manufacturing,Facilities and infrastructure,Medical devices,Regulatory Affairs,Supply Chain & Logistics

    Trelleborg gains ISO certification for Costa Rica medtech plant

    Trelleborg Medical Solutions has secured ISO 13485:2016 certification for its [...]

    April 22, 2026
  • CDMOs & Manufacturing,Drug discovery,Ingredients,Manufacturing,Sustainability,Technology and platforms

    Merck launches bio-based HPLC solvents for pharma labs

    Merck has launched a portfolio of bio-based solvents for high-performance [...]

    April 22, 2026
  • CDMOs & Manufacturing,Healthcare leadership,Market Access & Commercialization,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week

    Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]

    April 20, 2026
  • CDMOs & Manufacturing,Drug Development,European biotech,Logistics and distribution,Oncology,Partnerships & Funding,Supply Chain & Logistics

    Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research

    Oncodesign Services has expanded its collaboration with French research institute [...]

    April 18, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Development,Manufacturing,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow

    Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

    April 17, 2026
  • CDMOs & Manufacturing,Facilities and infrastructure,Manufacturing,Pharmaceuticals and therapeutics

    Symbiosis expands QC capabilities with new 30°C stability chamber

    Symbiosis Pharmaceutical Services has expanded its quality control laboratory in [...]

    April 10, 2026
  • CDMOs & Manufacturing,Supply Chain & Logistics

    Ofichem unifies CDMO and pharmaceutical supply brands under single identity

    Ofichem has consolidated its multiple business units into a single [...]

    April 9, 2026
  • CDMOs & Manufacturing,Cell & Gene Therapy,Immunology,Oncology,Pharmaceuticals and therapeutics,Rare Diseases,Research & Development

    ImmuneOncia Therapeutics and Lonza agree manufacturing partnership for PD-L1 antibody Danburstotug

    ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

    March 31, 2026
  • CDMOs & Manufacturing,Manufacturing,Market Access & Commercialization,Pharmaceuticals and therapeutics

    Vetter recognised as 2026 CDMO Leadership Awards winner in finished dose category

    Vetter has been named winner in the Finished Dose category [...]

    March 31, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Manufacturing,Partnerships & Funding

    Thermo Fisher and SHL Medical partner on integrated drug-device manufacturing in US

    Thermo Fisher Scientific and SHL Medical partner to integrate fill-finish, [...]

    March 27, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top